Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 48.00
Bid: 47.00
Ask: 49.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.255%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 48.00
MIG3 Live PriceLast checked at -
Maven Income and Growth VCT 3 is an Investment Trust

To achieve long-term capital appreciation and generate income for Shareholders by investing in a diversified portfolio of securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re Offer for Subscription

22 Sep 2017 18:25

RNS Number : 6312R
Maven Income & Growth VCT 4 PLC
22 September 2017
 

Joint Announcement

 

Offer for Subscription

 

22 September 2017

The board of directors of Maven Income and Growth VCT 3 PLC ("Maven VCT 3") and Maven Income and Growth VCT 4 PLC ("Maven VCT 4") (together the "Companies" and each a "Company") are pleased to announce that they have published a joint Prospectus (comprising a Securities Note, Registration Document and Summary) in relation to offers for subscription for new Ordinary Shares of 10p each in the Companies to raise, in aggregate, up to £30 million with over-allotment facilities of up to, in aggregate, a further £10 million (before issue costs) (the "Offers").

 

The Companies have also published a joint circular (the "Circular") seeking the approval of their respective shareholders for matters in connection with the Offers, each Company giving notice of a general meeting to be held on 8 November 2017 (the "General Meeting").

 

The Offers will open on 22 September 2017 and are expected to close no later than 3 April 2018 in relation to the tax year 2017/18 and on 20 April 2017 in relation to the tax year 2018/19 (unless the relevant Offer is fully subscribed by an earlier date or previously extended by the relevant board to no later than 14 September 2018).

 

Each Offer is conditional on the passing of all the resolutions at the relevant General Meeting.

Pursuant to individual offer agreements dated 22 September 2017 relating to each Offer between, among others, each relevant Company and Maven Capital Partners LLP ("Maven"), Maven, as the administrator of the Offer, will receive an offer administration fee of 2.5% of the application amount in relation to each accepted application, with reductions to the fee applying in certain cases (for instance, early applications under the Offers). Maven as the investment manager of each Company is a related party of each Company under the Listing Rules, and the payment of such a fee by the Company to Maven is a transaction to which Listing Rule 11.1.10R applies.

Further, William Nixon has expressed his intention, prior to the close of each of the Offers, to subscribe £50,000 in Maven VCT 3 and £50,000 in Maven VCT 4 under the relevant Offer. As a director of each of the Companies, William Nixon is a related party of the relevant Company under the Listing Rules and consequently each subscription is a transaction to which Listing Rule 11.1.10R applies.

Maven VCT 3 has also agreed with Maven that with effect from 1 December 2017 Maven will also be entitled to a performance incentive fee, for each six month period ending 31 May and 30 November, of an amount equal to 15% of any increase in the total return (before applying any performance incentive fee) as at the end of the relevant six month period to the total return (after accruing for the performance incentive fee payable for that period) compared to the end of the last six month period on which a performance incentive fee was paid. Payments in relation to any performance incentive fee shall not exceed £890,000 in relation to any rolling twelve month period ending on the date of the proposed payment. Maven and Maven VCT 3 have also agreed to vary the terms of a co-investment agreement (which enables employees and officers of Maven to co-invest with Maven VCT 3 in certain new and follow-on investments) with the effect that the 8% total investment limit (which applies to the investments that can be made by such employees and officers) will be reduced to 5% with effect from 1 December 2017. As Maven is a related party of Maven VCT 3 under the Listing Rules, the introduction of a performance incentive fee payable by that Company to Maven, together with the variation of the co-investment arrangements, are transactions to which Listing Rule 11.1.10R applies.

To obtain a copy of the Securities Note, private investors and financial advisers should call Maven Capital Partners LLP on 0141 306 7400. A downloadable version of the Securities Note will also be available from the each of the Company's websites: http://www.mavencp.com/migvct3 and http://www.mavencp.com/migvct4 .

 

Copies of the Prospectus and Circular are available, free of charge, from Maven Capital Partners UK LLP at Kintyre House, 205 West George Street, Glasgow G2 2LW.

 

In accordance with the Listing Rules, the Prospectus and Circular have been submitted to the National Storage Mechanism and will shortly be available for inspection at:

 

www.morningstar.co.uk/uk/NSM.

 

Any enquiries in respect of the Offers should be directed to:

Maven Capital Partners UK LLP

Telephone: 0141 306 7400E-mail: enquiries@mavencp.com

Maven Capital Partners UK LLPSecretary

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRPGUWPBUPMGMP
Date   Source Headline
23rd May 20122:29 pmRNSTransaction in Own Shares
22nd May 20125:12 pmRNSTransaction in Own Shares
4th May 20125:22 pmRNSDirector/PDMR Shareholding
4th May 201212:18 pmRNSAnnual Information Update
3rd May 201211:47 amRNSResult of AGM
1st May 20122:59 pmRNSInterim Management Statement
20th Apr 20121:31 pmRNSIssue of Equity
20th Apr 20121:09 pmRNSIssue of Equity
10th Apr 20129:48 amRNSIssue of Equity
27th Mar 201211:03 amRNSTransaction in Own Shares
23rd Mar 20124:55 pmRNSTransaction in Own Shares
20th Mar 201210:56 amRNSTransaction in Own Shares
19th Mar 201212:23 pmRNSTransaction in Own Shares
16th Mar 20124:43 pmRNSDirector/PDMR Shareholding
16th Mar 20123:05 pmRNSTransaction in Own Shares
13th Mar 201212:10 pmRNSAnnual Financial Report
8th Mar 201210:57 amRNSDirector/PDMR Shareholding
2nd Mar 20129:37 amRNSIssue of Equity
7th Dec 20114:22 pmRNSIssue of Equity
2nd Dec 20112:56 pmRNSTransaction in Own Shares
30th Nov 20114:26 pmRNSTransaction in Own Shares
28th Nov 20112:44 pmRNSTransaction in Own Shares
22nd Nov 20114:29 pmRNSTransaction in Own Shares
21st Nov 20114:56 pmRNSTransaction in Own Shares
18th Nov 20115:12 pmRNSTransaction in Own Shares
16th Nov 20112:36 pmRNSTransaction in Own Shares
15th Nov 201111:41 amRNSTransaction in Own Shares
15th Nov 201111:31 amRNSDirector/PDMR Shareholding
11th Nov 20113:17 pmRNSTransaction in Own Shares
10th Nov 201111:20 amRNSDirector/PDMR Shareholding
4th Nov 20113:59 pmRNSTransaction in Own Shares
3rd Nov 20112:51 pmRNSTransaction in Own Shares
2nd Nov 20112:54 pmRNSTransaction in Own Shares
25th Oct 20115:36 pmRNSTransaction in Own Shares
21st Oct 201110:51 amRNSTransaction in Own Shares
20th Oct 201111:37 amRNSTransaction in Own Shares
19th Oct 201111:38 amRNSTransaction in Own Shares
18th Oct 20114:59 pmRNSTransaction in Own Shares
17th Oct 20113:22 pmRNSTransaction in Own Shares
12th Oct 20113:33 pmRNSInterim Management Statement
26th Aug 20114:56 pmRNSDirector/PDMR Shareholding
19th Jul 20112:02 pmRNSDirector/PDMR Shareholding
8th Jul 20114:02 pmRNSHalf Yearly Report
2nd Jun 201110:38 amRNSDirector/PDMR Shareholding
25th May 201110:30 amRNSAnnual Information Update
19th May 201111:42 amRNSDirector/PDMR Shareholding
5th May 201110:54 amRNSResult of AGM
5th May 201110:23 amRNSInterim Management Statement
4th May 20113:24 pmRNSIssue of Equity
14th Apr 20115:44 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.